These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2310834)

  • 21. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.
    Dey BR; McAfee S; Colby C; Sackstein R; Saidman S; Tarbell N; Sachs DH; Sykes M; Spitzer TR
    Biol Blood Marrow Transplant; 2003 May; 9(5):320-9. PubMed ID: 12766882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a simplified counterflow centrifugation elutriation procedure for depletion of lymphocytes from human bone marrow.
    Noga SJ; Donnenberg AD; Schwartz CL; Strauss LC; Civin CI; Santos GW
    Transplantation; 1986 Feb; 41(2):220-9. PubMed ID: 2935979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.
    Min CK; Kim DW; Lee JW; Min WS; Kim CC
    Acta Haematol; 2000; 104(4):185-92. PubMed ID: 11279309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow transplantation of chronic myelogenous leukemia in chronic phase: evaluation of risks and benefits.
    Wagner JE; Zahurak M; Piantadosi S; Geller RB; Vogelsang GB; Wingard JR; Saral R; Griffin C; Shah N; Zehnbauer BA
    J Clin Oncol; 1992 May; 10(5):779-89. PubMed ID: 1569450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of graft-versus-host disease and the induction of transplant tolerance by low-dose UV-B irradiation of BM cells combined with cyclosporine immunosuppression.
    Ohajekwe OA; Hardy MA; Oluwole SF
    Transplantation; 1995 Dec; 60(12):1510-6. PubMed ID: 8545883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
    Körbling M; Huh YO; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth AB; Champlin RE
    Blood; 1995 Oct; 86(7):2842-8. PubMed ID: 7545476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases.
    McDonough CH; Jacobsohn DA; Vogelsang GB; Noga SJ; Chen AR
    Bone Marrow Transplant; 2003 Jun; 31(12):1073-80. PubMed ID: 12796786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunophenotyping study of bone marrow fractions obtained by elutriation in allogeneic bone marrow transplantation].
    Merino A; Urbano-Ispizua A; Marín P; Besson I; Carreras E; Sierra J; Salgado C; Rovira M; Grañena A; Montserrat E
    Sangre (Barc); 1993 Oct; 38(5):359-64. PubMed ID: 8140496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended-cycle elutriation to adjust T-cell content in HLA-disparate bone marrow transplantation.
    Quinones RR; Gutierrez RH; Dinndorf PA; Gress RE; Ney AB; Taylor B; Karandish S; Carter CS; Luban NL; Reaman GH
    Blood; 1993 Jul; 82(1):307-17. PubMed ID: 8324231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Favourable outcome of patients older than 40 years of age after transplantation with marrow grafts depleted of lymphocytes by counterflow centrifugation.
    Bär BM; De Witte T; Schattenberg A; Boezeman J; Hoogenhout J
    Br J Haematol; 1990 Jan; 74(1):53-60. PubMed ID: 2310697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial.
    Bolaños-Meade J; Cooke KR; Gamper CJ; Ali SA; Ambinder RF; Borrello IM; Fuchs EJ; Gladstone DE; Gocke CB; Huff CA; Luznik L; Swinnen LJ; Symons HJ; Terezakis SA; Wagner-Johnston N; Jones RJ; Brodsky RA
    Lancet Haematol; 2019 Apr; 6(4):e183-e193. PubMed ID: 30878319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
    Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
    Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.
    Soiffer RJ; Weller E; Alyea EP; Mauch P; Webb IL; Fisher DC; Freedman AS; Schlossman RL; Gribben J; Lee S; Anderson KC; Marcus K; Stone RM; Antin JH; Ritz J
    J Clin Oncol; 2001 Feb; 19(4):1152-9. PubMed ID: 11181681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases.
    McGlave PB; Beatty P; Ash R; Hows JM
    Blood; 1990 Apr; 75(8):1728-32. PubMed ID: 2328322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
    Topolsky D; Crilley P; Styler MJ; Bulova S; Brodsky I; Marks DI
    Bone Marrow Transplant; 1996 Apr; 17(4):549-54. PubMed ID: 8722353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
    Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
    Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up after allogeneic granulocyte colony-stimulating factor--primed bone marrow transplantation.
    Isola L; Scigliano E; Fruchtman S
    Biol Blood Marrow Transplant; 2000; 6(4A):428-33. PubMed ID: 10975511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.